This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of middle ear and respiratory system
CD2_INSITU_EAR_RESP_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ auris mediae sive systematis respiratorii
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of middle ear and respiratory system
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of middle ear and respiratory system
- In situ neoplasms
- In situ neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 165 | 44 | 121 |
| Unadjusted period prevalence (%) | 0.04 | 0.01 | 0.05 |
| Median age at first event (years) | 68.56 | 66.30 | 69.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 158
- Matched controls
- 1581
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D02.0
ICD-10 Finland
Carcinoma in situ: Larynx
+∞
52.0
47
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
50.8
46
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
128.4
44.6
46
5
130
Kela drug reimbursment
Malignant tumour
+∞
40.4
37
*
WF002
NOMESCO Finland
Radical radiotherapy
384.9
32.1
31
*
DQA10
NOMESCO Finland
Biopsy of larynx
369.0
31.0
30
*
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
122.5
28.8
30
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
91.7
27.9
30
*
ZXC10
NOMESCO Finland
Use of laser
42.4
25.4
31
9
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
11.5
25.2
50
61
UDQ12
NOMESCO Finland
Flexible laryngoscopy
15.8
24.0
40
33
UGC12
NOMESCO Finland
Flexible bronchoscopy
11.3
22.4
44
52
J38.3
ICD-10 Finland
Other diseases of vocal cords
133.6
22.2
23
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
253.7
22.2
22
*
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
+∞
21.3
20
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
6.0
21.0
70
184
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
20.2
19
*
UDQ22
NOMESCO Finland
Microlaryngoscopy
80.0
19.2
21
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
19.1
18
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
214.4
19.0
19
*
8070/2-C32.0
ICD-O-3
Squamous cell carcinoma in situ, NOS, of glottis
+∞
18.1
17
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
18.1
17
*
J37.0
ICD-10 Finland
Chronic laryngitis
29.6
17.5
23
9
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
17.0
16
*
XX3DW
NOMESCO Finland
Time consuming IT work
10.9
16.4
32
36
8140/2-C34.1
ICD-O-3
Adenocarcinoma in situ, NOS, of upper lobe, lung
+∞
15.9
15
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.6
15.2
37
61
H02AB02
ATC
dexamethasone; systemic
63.0
15.1
17
*
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
+∞
14.8
14
*
C320, 8077, 2
ICD-O-3
NA
+∞
14.8
14
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
13.7
13
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
14.8
13.4
22
17
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
12.7
12
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
50.9
12.1
14
*
UJC01
NOMESCO Finland
Scopy of lower throat
50.9
12.1
14
*
WZC30
NOMESCO Finland
Teaching
6.8
12.0
31
55
D02.2
ICD-10 Finland
Carcinoma in situ: Bronchus and lung
+∞
11.6
11
*
D02.3
ICD-10 Finland
Carcinoma in situ: Other parts of respiratory system
+∞
11.6
11
*
DQB70
NOMESCO Finland
Total excision of vocal cord
+∞
11.6
11
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
11.6
11
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.0
11.4
16
8
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.8
10.9
25
37
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
10.6
54
194
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
117.5
10.6
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.5
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
10.5
10
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
10.5
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.3
10.4
42
123
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.5
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.5
9
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
9.5
9
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.1
9.2
22
35
GD1AD
NOMESCO Finland
Thorax CT examination
8.8
9.2
19
24
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
39.1
9.1
11
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
WX734
NOMESCO Finland
JET-ventilation
+∞
8.4
8
*
2310A
ICD-9 Finland
Carcinoma in situ of respiratory system, Larynx
+∞
8.4
8
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
8.4
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
8.4
8
*
DQB30
NOMESCO Finland
Laryngectomy
+∞
8.4
8
*
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
+∞
8.4
8
*
WX402
NOMESCO Finland
General anaesthesia
4.1
7.7
30
85
JN4BD
NOMESCO Finland
Extensive body CT
5.5
7.6
22
45
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
83.9
7.5
8
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
8070/2-C32.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of larynx, NOS
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
UDQ02
NOMESCO Finland
Direct laryngoscopy
41.9
6.8
8
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.7
6.5
13
16
N02AA05
ATC
oxycodone; systemic
3.5
6.4
30
99
A04AA01
ATC
ondansetron; systemic, rectal
19.0
6.3
9
5
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
+∞
6.3
6
*
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
+∞
6.3
6
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
6.3
6
*
8070/2-C34.3
ICD-O-3
Squamous cell carcinoma in situ, NOS, of lower lobe, lung
+∞
6.3
6
*
8140/2-C34.3
ICD-O-3
Adenocarcinoma in situ, NOS, of lower lobe, lung
+∞
6.3
6
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
6.3
6
*
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
6.1
77
455
TQW99
NOMESCO Finland
Other minor procedure on skin
6.3
6.0
15
26
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
36
32
14.11
35.71
1.8
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
82
310
4.27
19.05
3.8
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
12
11.67
12.11
1.2
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
64
4.64
10.13
6.9
1.5
ug/l
5.4
7.3
0.16
26
47
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
27
6.45
9.31
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
26
70
4.22
9.03
1.4
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
119
3.34
8.07
1.2
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
41
4.81
7.64
2.5
4.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
8
14.61
6.99
1.5
1.4
ug/l
14.4
11.4
—
11
8
(3032080) INR in Blood by Coagulation assay
86
521
2.36
6.81
11.7
10.1
inr
1.3
1.4
0.39
21
144
(3042936) Bacteria identified in Isolate by Culture
41
181
2.68
6.38
1.8
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
63
341
2.37
6.37
2.9
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
66
373
2.28
5.97
4.3
2.0
mmol/l
2.3
2.3
0.02
58
293
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
79
481
2.23
5.97
4.9
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
17
6.20
5.70
1.7
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
18
5.85
5.39
2.8
2.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
0
+∞
5.23
1.2
0.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
88
582
2.10
5.17
7.3
5.5
mmol/l
1.2
1.2
0.09
79
489
(3013650) Neutrophils [#/volume] in Blood by Automated count
89
592
2.09
5.14
11.2
5.7
e9/l
4.6
4.6
0.00
81
507
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
24
4.84
4.86
1.5
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
59
342
2.13
4.84
4.6
3.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
21
5.00
4.59
1.7
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
74
476
2.01
4.53
5.1
5.0
%
63.0
58.4
2.71
69
431
(3022096) Basophils/100 leukocytes in Blood
72
460
2.00
4.48
5.2
4.9
%
0.7
0.6
0.25
67
413
(3006504) Eosinophils/100 leukocytes in Blood
73
472
1.98
4.36
5.2
5.1
%
2.6
2.9
0.58
68
425
(3002030) Lymphocytes/100 leukocytes in Blood
74
482
1.97
4.32
5.3
5.3
%
22.3
26.1
2.68
67
430
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
79
531
1.94
4.17
6.8
5.3
mmol/l
1.2
1.2
0.30
73
461
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
10
8.34
4.11
1.9
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
257
2.10
4.07
3.3
2.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
28
4.14
4.05
1.5
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
72
475
1.92
3.97
5.4
5.3
%
9.6
8.9
1.05
67
428
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
11
7.58
3.90
1.1
1.3
—
—
—
0
0
(3019225) pH of Specimen
27
127
2.35
3.60
3.3
3.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
75
515
1.84
3.56
4.7
4.8
e9/l
0.7
0.6
2.00
66
432
(3019198) Lymphocytes [#/volume] in Blood
76
527
1.82
3.47
4.9
4.9
e9/l
1.7
1.8
0.48
68
453
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
64
423
1.84
3.40
2.8
3.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
10
7.25
3.40
1.9
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
75
521
1.81
3.39
4.7
4.8
e9/l
0.0
0.0
0.25
66
444
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
14
5.94
3.38
1.8
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
56
357
1.86
3.33
4.6
4.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
80
2.55
3.20
2.4
3.9
%
0.4
0.9
—
8
23
(3021440) Promyelocytes/100 leukocytes in Blood
18
75
2.57
3.09
2.3
4.0
%
0.0
0.1
—
8
20
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
5
10.25
3.00
2.4
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
5
10.25
3.00
2.4
1.4
—
—
—
0
0
(4010399)
19
83
2.46
2.97
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
119
2.19
2.84
1.8
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
50
323
1.79
2.79
4.3
3.5
ph
7.4
7.4
0.32
14
50
(3013115) Eosinophils [#/volume] in Blood
75
544
1.69
2.77
4.9
4.8
e9/l
0.2
0.2
0.16
69
467
(40768800) Prostate Pathology biopsy report
5
6
8.54
2.76
1.0
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
43
267
1.83
2.72
5.1
3.3
%
91.7
83.5
1.26
43
260
(40760892) CBC W Ordered Manual Differential panel - Blood
34
196
1.93
2.70
4.1
4.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
32
181
1.95
2.68
2.3
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
16
69
2.46
2.57
2.6
4.2
%
0.0
1.0
—
5
16
(3025159) Blasts/100 leukocytes in Blood
16
69
2.46
2.57
2.6
4.1
%
0.0
0.1
—
7
17
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
7
7.32
2.56
2.2
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
118
2.10
2.50
1.9
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
99
787
1.64
2.47
4.8
4.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
46
305
1.70
2.30
3.0
2.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
15
4.11
2.06
1.5
1.5
%
86.4
89.7
—
6
15
(1616796) Gas panel - Central venous blood
8
26
3.18
2.04
6.0
3.3
—
—
—
0
0
(3000492) Spirometry study
17
84
2.14
2.04
1.6
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
57
411
1.59
2.04
3.2
3.5
e6/l
346.5
95.8
0.62
42
283
(3002582) Erythrocytes [#/volume] in Urine
51
358
1.61
2.03
3.0
3.0
e6/l
118.6
289.6
0.40
41
264
(3007853) Bacteria identified in Skin by Aerobe culture
24
137
1.88
1.96
1.5
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
22
3.28
1.90
1.0
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
17
3.62
1.85
2.3
1.4
mmol/l
1.7
2.0
—
6
17
(3018677) aPTT in Platelet poor plasma by Coagulation assay
32
204
1.71
1.83
3.1
1.7
s
30.2
29.6
0.19
32
194
(3000850) Epithelial cells [#/volume] in Urine
37
246
1.65
1.81
2.9
2.2
e6/l
7.6
3.7
0.48
32
199
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
31
2.66
1.68
2.0
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
25
155
1.72
1.58
2.0
1.9
%
1.6
1.6
0.13
25
136
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
2.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
58
2.15
1.53
11.2
8.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
21
2.92
1.52
1.7
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
21
2.92
1.52
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
52
2.20
1.48
3.2
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
45
329
1.51
1.47
3.1
2.9
e6/l
1.4
0.5
0.53
36
230
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.19
1.45
2.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
22
2.79
1.45
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
90
1.86
1.39
2.5
2.3
ml/min/173m2
56.0
54.2
—
6
35
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
17
3.00
1.37
2.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
47
352
1.47
1.36
3.1
2.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
18
106
1.78
1.36
3.7
6.3
mmol/l
10.1
11.2
0.23
18
100
(3017143) Hepatitis C virus Ab [Presence] in Serum
13
69
1.96
1.32
1.0
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
11
55
2.07
1.30
3.8
2.9
pmol/l
4.1
4.3
0.31
11
45
(3024354) Oxygen [Partial pressure] in Venous blood
17
100
1.78
1.29
2.2
2.8
kpa
4.6
4.2
0.34
17
93
(40761536) Microorganisms panel - Urine sediment
15
86
1.82
1.24
4.5
3.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.68
1.22
2.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
19
2.68
1.22
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
19
2.68
1.22
1.2
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
102
1.74
1.22
4.9
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
81
682
1.37
1.18
4.9
3.0
u/l
62.7
52.2
0.45
73
617
(3020630) Protein [Mass/volume] in Serum or Plasma
17
103
1.73
1.18
1.6
1.9
g/l
68.1
66.9
0.34
17
91
(3021589) Normoblasts [#/volume] in Blood
59
472
1.39
1.18
14.2
8.5
e9/l
0.0
0.0
0.44
43
375
(40760888) Immunoglobulin light chains.free panel - Serum
5
20
2.54
1.16
1.6
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
90
1.73
1.08
1.6
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
23
157
1.54
1.03
8.3
6.4
mmol/l
3.5
1.5
1.42
18
122
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
94
823
1.33
1.01
5.0
3.7
pmol/l
15.6
15.1
0.99
85
716
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
62
511
1.34
1.01
2.4
2.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
23
2.21
0.98
4.0
2.7
g/l
3.7
4.3
—
5
23
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
32
0.00
0.96
0.0
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
54
439
1.34
0.95
1.8
2.2
nmol/l
84.9
76.5
0.77
47
369
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
135
1.55
0.94
6.1
3.0
—
—
—
0
0
(1002224) Polysomnography panel
6
27
2.27
0.94
1.2
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
52
1.77
0.94
1.9
1.2
g/l
8.6
10.7
—
9
46
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
28
2.18
0.92
1.3
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
64
540
1.30
0.86
5.5
5.0
estimate
0.0
0.0
0.00
18
86
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
25
181
1.45
0.86
4.4
4.8
%
32.5
32.0
0.08
17
117
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
57
1.80
0.85
1.7
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
37
289
1.36
0.84
4.7
3.4
—
—
—
0
0
(3013512) EKG study
51
419
1.31
0.83
6.1
4.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
8
47
1.74
0.82
2.1
1.2
g/l
1.3
0.3
—
8
42
(3009445) Proteinase 3 Ab [Units/volume] in Serum
8
47
1.74
0.82
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
8
47
1.74
0.82
2.1
1.2
g/l
41.7
37.0
—
8
39
(3035350) Ketones [Presence] in Urine by Test strip
63
537
1.28
0.78
4.0
3.7
estimate
0.0
0.0
0.00
17
87
(3009261) Glucose [Presence] in Urine by Test strip
64
548
1.27
0.76
4.0
3.8
estimate
0.0
0.0
0.00
17
81
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
76
1.62
0.74
1.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
25
2.03
0.73
5.8
2.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
57
1.61
0.72
1.9
1.3
g/l
2.9
3.2
—
9
46
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
64
551
1.26
0.72
5.5
3.9
ng/l
52.5
49.5
0.05
55
418
(1761482) Bacteria [#/volume] in Urine by Culture
7
40
1.78
0.72
1.7
3.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
26
1.95
0.71
2.6
1.8
u/ml
10.4
12.9
—
5
19
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
58
1.58
0.71
1.9
1.3
g/l
3.4
3.8
—
9
45
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
58
1.58
0.71
1.9
1.3
g/l
7.1
7.7
—
9
47
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
58
1.58
0.71
1.9
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
41
337
1.29
0.66
1.4
1.5
nmol/l
20.8
21.4
0.08
33
279
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
122
1139
1.27
0.65
25.8
13.4
mg/l
30.2
26.6
0.58
111
893
(3013707) Erythrocyte sedimentation rate by Westergren method
94
853
1.24
0.65
5.1
4.0
mm/h
15.5
12.9
0.72
84
761
(3022313) Gas panel - Capillary blood
11
71
1.59
0.64
2.7
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
37
302
1.29
0.63
4.3
4.0
estimate
0.0
0.0
0.00
14
80
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
51
1.60
0.61
1.8
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
54
464
1.24
0.61
3.5
3.1
ng/l
743.3
1694.2
2.32
47
389
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.2
—
2.1
—
0
5
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
81
1.52
0.59
1.4
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
31
250
1.30
0.58
6.6
4.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
35
290
1.26
0.54
2.0
1.8
nmol/l
1184.5
1209.4
0.07
30
213
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
40
1.52
0.52
1.0
1.2
—
—
—
0
0
(3015736) pH of Urine
49
424
1.22
0.51
4.0
3.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
67
1.52
0.51
2.2
2.3
%
1.4
1.2
—
10
67
(3044889) 12 lead EKG panel
90
827
1.19
0.50
5.0
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
111
1041
1.20
0.48
6.0
4.5
mu/l
1.9
2.0
0.19
99
909
(3004789) Transferrin [Mass/volume] in Serum or Plasma
21
165
1.31
0.48
2.0
2.4
g/l
2.2
2.2
0.02
21
151
(3003694) ABO and Rh group [Type] in Blood
31
257
1.25
0.48
1.5
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
49
428
1.21
0.47
4.8
3.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
29
241
1.25
0.44
2.0
1.7
mg/l
1.1
1.2
0.14
22
189
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
12
160
0.73
0.42
1.2
1.3
u/ml
54.1
16.1
—
5
49
(3052851) Hemolysis interference index of Serum or Plasma
5
33
1.53
0.41
2.6
3.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.9
—
23.8
—
0
5
(1761868) Lipid panel - Serum or Plasma
30
353
0.82
0.41
3.8
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
151
1.29
0.41
1.5
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
35
1.44
0.39
5.8
1.9
kpa
7.5
7.9
—
5
28
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
35
1.44
0.39
2.2
1.2
mg/l
22.4
38.4
—
5
29
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
35
1.44
0.39
2.2
1.2
mg/l
45.4
58.8
—
5
29
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
198
1.25
0.39
2.2
2.8
e6/l
1.3
1.1
0.05
15
109
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
112
1062
1.17
0.38
24.6
12.8
ml/min/173m2
74.6
72.6
0.49
100
851
(3014576) Chloride [Moles/volume] in Serum or Plasma
20
162
1.27
0.37
6.6
6.1
mmol/l
104.0
104.1
0.02
20
157
(3017446) Testosterone [Moles/volume] in Serum or Plasma
12
90
1.36
0.37
1.7
2.2
nmol/l
7.4
15.4
3.27
12
73
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
71
1.28
0.37
1.9
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
79
0.62
0.36
3.6
2.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
110
1152
0.86
0.34
5.3
5.6
mmol/l
2.4
2.5
1.15
100
1036
(3026493) Urate [Moles/volume] in Serum or Plasma
36
315
1.18
0.34
2.3
2.6
umol/l
356.9
9422.7
1.78
28
267
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
176
0.78
0.34
1.1
1.2
iu/ml
48.0
46.6
—
6
57
(3009508) Creatinine [Moles/volume] in Urine
47
421
1.16
0.34
3.3
3.2
mmol/l
7.4
7.5
0.08
36
341
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
26
303
0.83
0.33
2.0
1.9
pmol/l
426.6
24152966.9
0.50
20
236
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
61
559
1.14
0.32
2.2
2.0
pmol/l
102.7
94.5
0.79
42
298
(3011397) Hemoglobin [Presence] in Urine by Test strip
22
259
0.83
0.31
3.5
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
119
0.74
0.28
2.1
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
119
0.74
0.28
1.1
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
46
417
1.14
0.28
3.4
3.2
mg/l
42.2
217.1
0.60
29
271
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
103
1076
0.89
0.28
4.4
4.5
mmol/l
1.3
1.3
0.11
92
956
(3000991) Gas panel - Venous blood
13
104
1.27
0.27
9.1
8.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
107
1113
0.89
0.26
4.7
5.0
mmol/l
1.4
1.4
0.24
97
1000
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
189
1.19
0.26
2.2
3.0
e6/l
1.6
1.8
0.07
13
101
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
70
657
1.11
0.24
5.9
4.1
ug/l
2.3
2.1
0.11
61
569
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
37
1.36
0.24
1.4
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
40
1.26
0.22
5.8
2.1
mmol/l
25.5
24.1
—
5
30
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
48
513
0.91
0.18
5.8
3.9
%
22.7
24.8
0.45
31
257
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
109
1123
0.91
0.18
4.7
5.0
mmol/l
4.3
4.4
0.12
99
1015
(40761535) Cells panel - Urine sediment
13
110
1.20
0.17
4.0
3.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
117
1138
1.10
0.17
5.6
5.1
mmol/l
6.3
6.2
0.57
106
1003
(3020682) Albumin/Creatinine [Ratio] in Urine
48
449
1.10
0.17
4.6
4.1
mg/mmol
3.1
8.4
1.67
28
288
(3000330) Specific gravity of Urine by Test strip
8
69
1.17
0.17
2.0
3.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
77
0.77
0.16
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
110
0.81
0.13
1.6
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
122
1202
1.06
0.08
31.3
16.2
umol/l
87.9
87.3
0.05
122
1202
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
74
0.80
0.07
2.2
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
83
0.84
0.07
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
119
1173
1.05
0.07
26.3
13.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
17
179
0.94
0.03
1.2
1.3
g/l
2.7
3.0
0.25
12
103
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
110
1109
0.98
0.02
8.2
6.9
mmol/mol
41.6
41.4
0.09
99
1009
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
16
167
0.95
0.01
5.1
8.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
20
204
0.98
0.00
25.7
25.3
inr
1.3
1.3
—
7
26
(3009542) Hematocrit [Volume Fraction] of Blood
98
975
1.01
0.00
24.2
15.0
%
38.5
38.7
0.03
50
585
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
34
342
0.99
0.00
3.4
2.7
ug/l
0.9
0.8
0.24
26
240
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
80
1.00
0.00
2.4
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
0.4
—
0
5
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
7.5
—
0
5
(3028707) Methadone [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.7
—
0
6
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
26.8
—
0
5
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
95
0.94
0.00
1.2
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
52
0.96
0.00
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
6
64
0.94
0.00
3.3
4.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
4.3
—
0
5
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.2
—
6.4
—
0
9
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
8.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
64
0.94
0.00
2.5
2.2
ug/l
68.6
418.2
—
6
57
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
126.9
—
0
8
(4027681)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
18.4
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.1
—
2.5
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
71.3
—
0
7
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
270.3
—
0
6
(3016018) Differential panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_EAR_RESP_EXALLC – Carcinoma in situ of middle ear and respiratory system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).